TD Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-93,385
| Closed | -$3.11M | – | 1426 |
|
|
2020
Q2 | $3.11M | Buy |
93,385
+4,200
| +5% | +$140K | ﹤0.01% | 771 |
|
|
2020
Q1 | $2.43M | Buy |
89,185
+4,400
| +5% | +$120K | ﹤0.01% | 786 |
|
|
2019
Q4 | $1.67M | Buy |
84,785
+8,101
| +11% | +$160K | ﹤0.01% | 967 |
|
|
2019
Q3 | $994K | Buy |
76,684
+4,300
| +6% | +$55.7K | ﹤0.01% | 1051 |
|
|
2019
Q2 | $901K | Sell |
72,384
-16,800
| -19% | -$209K | ﹤0.01% | 1068 |
|
|
2019
Q1 | $1.3M | Sell |
89,184
-1,300
| -1% | -$18.9K | ﹤0.01% | 993 |
|
|
2018
Q4 | $999K | Buy |
90,484
+41,484
| +85% | +$458K | ﹤0.01% | 1055 |
|
|
2018
Q3 | $1.29M | Buy |
+49,000
| New | +$1.29M | ﹤0.01% | 1100 |
|
|
2018
Q1 | – | Sell |
-13,500
| Closed | -$188K | – | 1387 |
|
|
2017
Q4 | $188K | Buy |
+13,500
| New | +$188K | ﹤0.01% | 1306 |
|
|
2016
Q1 | – | Sell |
-10,100
| Closed | -$150K | – | 1399 |
|
|
2015
Q4 | $150K | Hold |
10,100
| – | – | ﹤0.01% | 1327 |
|
|
2015
Q3 | $166K | Sell |
10,100
-73,300
| -88% | -$1.2M | ﹤0.01% | 1315 |
|
|
2015
Q2 | $1.9M | Sell |
83,400
-1,500
| -2% | -$34.2K | ﹤0.01% | 864 |
|
|
2015
Q1 | $1.29M | Buy |
+84,900
| New | +$1.29M | ﹤0.01% | 899 |
|
|
2014
Q2 | – | Sell |
-23,800
| Closed | -$277K | – | 1323 |
|
|
2014
Q1 | $277K | Buy |
23,800
+2,200
| +10% | +$25.6K | ﹤0.01% | 1171 |
|
|
2013
Q4 | $382K | Hold |
21,600
| – | – | ﹤0.01% | 1089 |
|
|
2013
Q3 | $311K | Buy |
21,600
+2,300
| +12% | +$33.1K | ﹤0.01% | 1101 |
|
|
2013
Q2 | $291K | Buy |
+19,300
| New | +$291K | ﹤0.01% | 1048 |
|